Latest Breaking News On - Joeld richter - Page 1 : comparemela.com

New therapy to mitigate fragile X syndrome may be on the horizon

An antisense therapy developed by Joel D. Richter, PhD, Sneha Shah, PhD, and Jonathan K. Watts, PhD, at UMass Chan Medical School and Elizabeth Berry-Kravis, MD, PhD, at RUSH University Medical Center, restores production of the protein FMRP in cell samples taken from patients with fragile X syndrome.

Huseyin mehmetElizabeth berry kravisMichael tranfagliaUmass chanDanielle ellisSneha shahArthurf koskinasJonathank wattsJoeld richterUniversity medical centerBusiness developmentSimons foundation for autism researchProceedings of the national academy sciencesNational institutes of healthUmass chan medical schoolResearch foundation

Antisense therapy restores fragile X protein production in human cells

Antisense therapy restores fragile X protein production in human cells
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Sneha shahArthurf koskinasElizabeth berry kravisJoeld richterJonathank wattsUniversity medical centerUmass chan medical schoolProceedings of the national academy sciencesNational academyChan medical schoolMedical center

Antisense Therapy Restores Fragile X Protein Production in Human Cells

Antisense Therapy Restores Fragile X Protein Production in Human Cells
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Jonathank wattsUmass chanJoeld richterHuseyin mehmetSneha shahMichael tranfagliaElizabeth berry kravisArthurf koskinasUmass chan medical schoolUniversity medical centerProceedings of the national academy sciencesNational institutes of healthResearch foundationSimons foundation for autism researchBusiness developmentChan medical school